1. Industry Programme Manager, clark@ebi.ac.uk.
Introduction to the second day & overview of ELIXIR Industry Stakeholders report
Dominic Clark,
Industry Programme Manager,

2. ELIXIR – European life sciences infrastructure for biological information
To build a sustainable European infrastructure for biological information supporting life science research and its translation to:
medicine,
the environment,
the bioindustries, and
society
32 participants in 13 countries

3. Sector of your organization
Academic/Non-profit (516)
Industry/Commercial/SME (61)
Response frequency = % of answering respondents (i.e. 577)

4. Select your country of location
Response frequency = % of answering respondents (i.e. 60)
India - USA

5. Importance of long-term sustainability of European bioinformatics infrastructures according to sector
Response frequency = % of answering respondents (as indicated for each sector category) .
Total number of answering respondents considered for this cross analysis was 564.

6. We use bioinformatics databases in order to
Multiple answer options – Response frequency = % of answering respondents (i.e. 60)

7. My group is most interested in the following biological data
Multiple answer options – Response frequency = % of answering respondents (i.e. 59)

8. Important databases according to sector
Useful
Essential
Multiple answer options - Answering respondents = 619
EMBL/GenBank/Entrez Nucleotide
UniProt/ Swiss-Prot/TrEMBL/Entrez Protein

9. What database developments are needed in the future?
Multiple answer options were authorized.
Response frequency = % of answering respondents (i.e. 46).

10. How important would the following be for your group?
Not relevant
Essential
Tool resources (response count) - Answering respondents = 61

11. Where there was a difference

12. Position Statement
A pan European informatics infrastructure and associated services are considered essential to support the European knowledge economy. This will not be achieved efficiently if such infrastructure were to be based on uncoordinated and disconnected national infrastructure efforts. This pan-European infrastructure should be attained through a well managed and maintained, service oriented, scalable, consumer focused delivery framework. It is essential for Elixir to deliver on these goals, requiring the adoption of a service culture by this project, to ensure a sustained return on investment to both academic and industrial experimental research in the EU.

13. ELIXIR Industry Stakeholders’ recommendations
Develop robust and scalable life science service infrastructure of enterprise quality, supported by transparent service level agreements defining outages, updates, performance, access levels and user training & support (etc).
Deliver infrastructure to comprise of ‘service components’ that include data, APIs, GUIs, search & analysis tools and training delivered to agreed process, syntactic and semantic standards.
Uphold the principle of unrestricted, open access to data and supported core analysis tools via web interface, programmatic and download methods. Together with industry stakeholders, Elixir should explore sustainable business models for open access to all Elixir services for all consumers.

15. SME Meeting Agenda 4rd September 2009
09.00
Introduction to the second day & overview of ELIXIR Industry Stakeholders report (Dominic Clark, EMBL-EBI)
09.10
EMBL-EBI Literature Services and Applications (Jo McEntyre, Head of Literature Services, EMBL-EBI)
09.40
EMBL-EBI Patent related services (Jennifer McDowell, EMBL-EBI).
10.10
EPO Services and Resources for SMEs and the FELICS project (Stephane Nauche, European Patent Office)
10.30
Patent Information ( The European Patent Office Open Patent Services Nigel Clarke (European Patent Office, Austria)
11.00
COFFEE
11.30
Patent Information: ( Nigel Clarke (European Patent Office, Austria)
12.00
How the EPO searches prior art in Biotech; European Patent Academy and dissemination of knowledge (Titus Vogt, European Patent Office)
12.30
Cheminformatics resources and services at EBI (Paula de Matos, EMBL-EBI).
12.55
Patent and Licensing Management (Angela Siegling)
13.05
Wrap up and discussion (Pascal Kahlem, EMBL-EBI)
13.20
LUNCH and end of meeting

17. Acknowledgements
The workshop is sponsored by a number of EU projects coordinated by EMBL-EBI that are targeted to provide bioinformatics tools and data resources for European research. These include:
ENFIN NoE
EMBRACE NoE
CALBC project
SLING project (formally FELICS)
ELIXIR project
We would like to thank everyone involved in the preparation of the agenda (Pascal Kahlem, Nina Sallacz, Stéphane Nauche, Holly Edwards)
We would like to thank all the speakers.
We are grateful to AWS (Nina Sallacz and colleagues) for their support and for hosting the meeting.